Search Results - Yingying HU

Application of Delphi method in the construction of holistic integrative pharmacy elective course system by Yong ZHANG, Yingying HU, Liangjun XIE, Shuyang ZHAO

Connect to this object online.

Combining 18F‐FDG PET/CT and Serum Lactate Dehydrogenase for Prognostic Evaluation of Small Cell Lung Cancer by Xiaoping Lin, Xiaoping Lin, Zizheng Xiao, Zizheng Xiao, Yingying Hu, Yingying Hu, Xu Zhang, Xu Zhang, Wei Fan, Wei Fan

Connect to this object online.

Breastfed 13 month-old infant of a mother with COVID-19 pneumonia: a case report by Yuanyuan Yu, Youjiang Li, Yingying Hu, Bin Li, Jian Xu

Connect to this object online.

A high throughput method for Monitoring of Sorafenib, regorafenib, cabozantinib and their metabolites with UPLC-MS/MS in rat plasma by Er-Min Gu, Ya-Nan Liu, Lvjun Pan, Yingying Hu, Xuemei Ye, Pingping Luo

Connect to this object online.

The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer by Tingting Lu, Yufan Huang, Zhongjie Cai, Wangchun Lin, Xiaoxiao Chen, Ruijia Chen, Yingying Hu

Connect to this object online.

Notoginsenoside R1 Protects Against the Acrylamide-Induced Neurotoxicity via Upregulating Trx-1-Mediated ITGAV Expression: Involvement of Autophagy by Wenjun Wang, Wenjun Wang, Lu Huang, Elizabeth Rosalind Thomas, Yingying Hu, Fancai Zeng, Xiang Li

Connect to this object online.

A newborn with seizures born to a mother diagnosed with primary carnitine deficiency by Si Chen, Yingying Hu, Yumei Huang, Yan Nan, Xiaojian Zhou, Shangqin Chen, Jin Lin, Zhenlang Lin

Connect to this object online.

Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung can... by Caolin Wang, Shan Xu, Liang Peng, Bingliang Zhang, Hong Zhang, Yingying Hu, Pengwu Zheng, Wufu Zhu

Connect to this object online.

Lack of pharmacokinetic interaction between derazantinib and naringin in rats by Ya-nan Liu, Jie Chen, Xinhao Xu, Yingying Hu, Jin-yu Hu, Ren-ai Xu, Guanyang Lin

Connect to this object online.

Activation of the Nrf2/Keap1 signaling pathway mediates the neuroprotective effect of Perillyl alcohol against cerebral hypoxic-ischemic damage in neonatal rats by Yu Fang, Yihui Zheng, Qiqi Gao, Mengdan Pang, Yiqing Wu, Xiaoli Feng, Xiaoyue Tao, Yingying Hu, Zhenlang Lin, Wei Lin

Connect to this object online.

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects by Yingying Hu, Qiong Wei, Xingchen Bian, Xinyi Yang, Jicheng Yu, Jingjing Wang, Haijing Yang, Guoying Cao, Xiaojie Wu, Jing Zhang

Connect to this object online.

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers by Ruijia Chen, Yalan Zhang, Kongying Lin, Defu Huang, MaoJin You, Yanjin Lai, Jinye Wang, Yingying Hu, Na Li, Na Li

Connect to this object online.

Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics by Ya-nan Liu, Ya-nan Liu, Yingying Hu, Jing Wang, Jing Wang, Chaojie Chen, Jianping Cai, Ren-ai Xu, Zhongqiu Lu

Connect to this object online.

Myricetin attenuates hypoxic-ischemic brain damage in neonatal rats via NRF2 signaling pathway by Tingting Chen, Tingting Chen, Yingying Hu, Yingying Hu, Liying Lu, Liying Lu, Qianlei Zhao, Qianlei Zhao, Xiaoyue Tao, Xiaoyue Tao, Bingqing Ding, Bingqing Ding, Shangqin Chen, Shangqin Chen, Jianghu Zhu, Jianghu Zhu, Xiaoling Guo, Xiaoling Guo, Xiaoling Guo, Xiaoling Guo, Zhenlang Lin, Zhenlang Lin, Zhenlang Lin

Connect to this object online.

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo by Ya-nan Liu, Ya-nan Liu, Xinhao Xu, Xinhao Xu, Jingjing Nie, Jingjing Nie, Yingying Hu, Xuegu Xu, Ren-ai Xu, Xiaoxiang Du

Connect to this object online.

Sarcopenia in Patients With Normal Body Mass Index Is an Independent Predictor for Postoperative Complication and Long‐Term Survival in Gastric Cancer by Xiangwei Sun, Jianfeng Xu, Xiaodong Chen, Weiteng Zhang, Wenjing Chen, Ce Zhu, Jing Sun, Xinxin Yang, Xiang Wang, Yingying Hu, Yiqi Cai, Xian Shen

Connect to this object online.

UPLC-MS/MS Technology for the Quantitative Methodology and Pharmacokinetic Analysis of Voxtalisib in Rat Plasma by Qingqing Li, Qingqing Li, Ya-nan Liu, Ya-nan Liu, Jing Wang, Jing Wang, Yingying Hu, Jinyu Hu, Ren-ai Xu, Liu Shao, Lianguo Chen

Connect to this object online.

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia by Xingchen Bian, Xingchen Bian, Xingchen Bian, Nanyang Li, Nanyang Li, Nanyang Li, Yi Li, Yi Li, Yi Li, Xu Zhu, Xu Zhu, Xu Zhu, Jicheng Yu, Jicheng Yu, Jicheng Yu, Yingying Hu, Yingying Hu, Yingying Hu, Haijing Yang, Haijing Yang, Haijing Yang, Qiong Wei, Qiong Wei, Qiong Wei, Xiaojie Wu, Xiaojie Wu, Xiaojie Wu, Jingjing Wang, Jingjing Wang, Jingjing Wang, Guoying Cao, Guoying Cao, Guoying Cao, Jufang Wu, Jufang Wu, Jufang Wu, Yang Wang, Jing Zhang, Jing Zhang, Jing Zhang, Jing Zhang, Jing Zhang

Connect to this object online.

LZM008, a proposed tocilizumab biosimilar: Pharmacokinetics, safety, and immunogenicity profiles compared with ACTEMRA® in Chinese healthy male subjects by Guoying Cao, Jingjing Wang, Jinjie He, Yingying Hu, Haijing Yang, Linling Que, Xianghong Gu, Jicheng Yu, Xiaojie Wu, Jufang Wu, Wei Fang, Qing He, Jing Zhang

Connect to this object online.

Aloe-Emodin Derivative, an Anthraquinone Compound, Attenuates Pyroptosis by Targeting NLRP3 Inflammasome in Diabetic Cardiomyopathy by Yingying Hu, Shuqian Zhang, Han Lou, Monayo Seth Mikaye, Run Xu, Ziyu Meng, Menghan Du, Pingping Tang, Zhouxiu Chen, Yongchao Chen, Xin Liu, Zhimin Du, Yong Zhang

Connect to this object online.